309 related articles for article (PubMed ID: 35485527)
1. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
[TBL] [Abstract][Full Text] [Related]
2. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
7. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.
Palleis C; Sauerbeck J; Beyer L; Harris S; Schmitt J; Morenas-Rodriguez E; Finze A; Nitschmann A; Ruch-Rubinstein F; Eckenweber F; Biechele G; Blume T; Shi Y; Weidinger E; Prix C; Bötzel K; Danek A; Rauchmann BS; Stöcklein S; Lindner S; Unterrainer M; Albert NL; Wetzel C; Rupprecht R; Rominger A; Bartenstein P; Herms J; Perneczky R; Haass C; Levin J; Höglinger GU; Brendel M
Mov Disord; 2021 Apr; 36(4):883-894. PubMed ID: 33245166
[TBL] [Abstract][Full Text] [Related]
9. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
10. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
[TBL] [Abstract][Full Text] [Related]
11. Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome.
Khosousi S; Hye A; Velayudhan L; Bloth B; Tsitsi P; Markaki I; Svenningsson P
Parkinsonism Relat Disord; 2023 Mar; 108():105313. PubMed ID: 36739794
[TBL] [Abstract][Full Text] [Related]
12. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
[TBL] [Abstract][Full Text] [Related]
13. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
[TBL] [Abstract][Full Text] [Related]
14. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
[TBL] [Abstract][Full Text] [Related]
15. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.
Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW
Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512
[TBL] [Abstract][Full Text] [Related]
17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
18. Progressive Supranuclear Palsy and Corticobasal Degeneration.
Coughlin DG; Dickson DW; Josephs KA; Litvan I
Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
[TBL] [Abstract][Full Text] [Related]
19. Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging.
Hess CP; Christine CW; Apple AC; Dillon WP; Aminoff MJ
AJNR Am J Neuroradiol; 2014 May; 35(5):897-903. PubMed ID: 24356677
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
Fernandes Gomes B; Farris CM; Ma Y; Concha-Marambio L; Lebovitz R; Nellgård B; Dalla K; Constantinescu J; Constantinescu R; Gobom J; Andreasson U; Zetterberg H; Blennow K
Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]